Horizon EU funded study of psilocybin to treat psychological distress in people requiring palliative care.
PsyPal is dedicated to advancing mental health care through innovative research and development. Focusing on enhancing the well-being of individuals facing significant life challenges, PsyPal operates at the forefront of psychological treatment and palliative care solutions.
Driven by a commitment to improving the quality of life for those in need, PsyPal engages in pioneering studies and collaborative projects. The organization strives to implement effective strategies and therapeutic interventions, reinforcing its role as a key contributor to the mental health sector.
PsyPal is continuously working to expand its capabilities and broaden its impact. More information about PsyPal, its projects, and ongoing initiatives will be completed soon with the support of the company’s management.
We invite the manager of PsyPal to create a customized and exclusive company showcase and product listing on our platform to further highlight your valuable contributions.
Other organizations in the same industry
This company is also known as